Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling

REFERENCES

• Ledwith BJ, Pauley CJ, Wagner LK, Rokos CL, Alberts DW, Manam S. 1997. Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12,13-myristate-type tumor promoters in immortalized mouse liver cells. J Biol Chem 272:3707–3714. http://dx.doi.org/10.1074/jbc.272.6.3707.
   PubMed Web of Science ®Google Scholar
• Martín-Sanz P, Callejas NA, Casado M, Díaz-Guerra MJ, Boscá L. 1998. Expression of cyclooxygenase-2 in foetal rat hepatocytes stimulated with lipopolysaccharide and pro-inflammatory cytokines. Br J Pharmacol 125:1313–1319. http://dx.doi.org/10.1038/sj.bjp.0702196.
   PubMedGoogle Scholar
• Simmons DL, Botting RM, Hla T. 2004. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56:387–437. http://dx.doi.org/10.1124/pr.56.3.3.
   PubMed Web of Science ®Google Scholar
• Casado M, Callejas NA, Rodrigo J, Zhao X, Dey SK, Bosca L, Martin-Sanz P. 2001. Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy. FASEB J 15:2016–2018. http://dx.doi.org/10.1096/fj.01-0158fje.
   PubMed Web of Science ®Google Scholar
• Rudnick DA, Perlmutter DH, Muglia LJ. 2001. Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration. Proc Natl Acad Sci U S A 98:8885–8890. http://dx.doi.org/10.1073/pnas.151217998.
   PubMedGoogle Scholar
• Yamamoto H, Kondo M, Nakamori S, Nagano H, Wakasa K, Sugita Y, Chang-De J, Kobayashi S, Damdinsuren B, Dono K, Umeshita K, Sekimoto M, Sakon M, Matsuura N, Monden M. 2003. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1. Gastroenterology 125:556–571. http://dx.doi.org/10.1016/S0016-5085(03)00904-1.
   PubMed Web of Science ®Google Scholar
• Kern MA, Haugg AM, Koch AF, Schilling T, Breuhahn K, Walczak H, Fleischer B, Trautwein C, Michalski C, Schulze-Bergkamen H, Friess H, Stremmel W, Krammer PH, Schirmacher P, Muller M. 2006. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Cancer Res 66:7059–7066. http://dx.doi.org/10.1158/0008-5472.CAN-06-0325.
   PubMedGoogle Scholar
• Mayoral R, Fernandez-Martinez A, Bosca L, Martin-Sanz P. 2005. Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells. Carcinogenesis 26:753–761. http://dx.doi.org/10.1093/carcin/bgi022.
   PubMed Web of Science ®Google Scholar
• Cusimano A, Fodera D, Lampiasi N, Azzolina A, Notarbartolo M, Giannitrapani L, D'Alessandro N, Montalto G, Cervello M. 2009. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. Ann N Y Acad Sci 1155:300–308. http://dx.doi.org/10.1111/j.1749-6632.2009.03701.x.
   PubMedGoogle Scholar
• Cheng AS, Yu J, Lai PB, Chan HL, Sung JJ. 2008. COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis. Biochem Biophys Res Commun 374:175–180. http://dx.doi.org/10.1016/j.bbrc.2008.06.098.
   PubMedGoogle Scholar
• Núñez O, Fernández-Martínez A, Majano PL, Apolinario A, Gómez-Gonzalo M, Benedicto I, López-Cabrera M, Boscá L, Clemente G, García-Monzón C, Martín-Sanz P. 2004. Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins. Gut 53:1665–1672. http://dx.doi.org/10.1136/gut.2003.038364.
   PubMed Web of Science ®Google Scholar
• Casado M, Molla B, Roy R, Fernandez-Martinez A, Cucarella C, Mayoral R, Bosca L, Martin-Sanz P. 2007. Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes. Hepatology 45:631–638. http://dx.doi.org/10.1002/hep.21556.
   PubMedGoogle Scholar
• Mayoral R, Molla B, Flores JM, Bosca L, Casado M, Martin-Sanz P. 2008. Constitutive expression of cyclo-oxygenase 2 transgene in hepatocytes protects against liver injury. Biochem J 416:337–346. http://dx.doi.org/10.1042/BJ20081224.
   PubMed Web of Science ®Google Scholar
• Frances DE, Motino O, Agra N, Gonzalez-Rodriguez A, Fernandez-Alvarez A, Cucarella C, Mayoral R, Castro-Sanchez L, Garcia-Casarrubios E, Bosca L, Carnovale CE, Casado M, Valverde AM, Martin-Sanz P. 24 November 2014, posting date. Hepatic cyclooxygenase-2 expression protects against diet-induced steatosis, obesity and insulin resistance. Diabetes http://dx.doi.org/10.2337/db14-0979.
   Google Scholar
• Frances DE, Ingaramo PI, Mayoral R, Traves P, Casado M, Valverde AM, Martin-Sanz P, Carnovale CE. 2013. Cyclooxygenase-2 over-expression inhibits liver apoptosis induced by hyperglycemia. J Cell Biochem 114:669–680. http://dx.doi.org/10.1002/jcb.24409.
   PubMedGoogle Scholar
• Winter J, Jung S, Keller S, Gregory RI, Diederichs S. 2009. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11:228–234. http://dx.doi.org/10.1038/ncb0309-228.
   PubMed Web of Science ®Google Scholar
• Fukuda T, Yamagata K, Fujiyama S, Matsumoto T, Koshida I, Yoshimura K, Mihara M, Naitou M, Endoh H, Nakamura T, Akimoto C, Yamamoto Y, Katagiri T, Foulds C, Takezawa S, Kitagawa H, Takeyama K, O'Malley BW, Kato S. 2007. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Biol 9:604–611. http://dx.doi.org/10.1038/ncb1577.
   PubMed Web of Science ®Google Scholar
• Ferreira DM, Simao AL, Rodrigues CM, Castro RE. 2014. Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease. FEBS J 281:2503–2524. http://dx.doi.org/10.1111/febs.12806.
   PubMedGoogle Scholar
• Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi M, Tacke F, Trautwein C, Luedde T. 2011. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53:209–218. http://dx.doi.org/10.1002/hep.23922.
   PubMed Web of Science ®Google Scholar
• Harper KA, Tyson-Capper AJ. 2008. Complexity of COX-2 gene regulation. Biochem Soc Trans 36:543–545. http://dx.doi.org/10.1042/BST0360543.
   PubMed Web of Science ®Google Scholar
• Chakrabarty A, Tranguch S, Daikoku T, Jensen K, Furneaux H, Dey SK. 2007. MicroRNA regulation of cyclooxygenase-2 during embryo implantation. Proc Natl Acad Sci U S A 104:15144–15149. http://dx.doi.org/10.1073/pnas.0705917104.
   PubMed Web of Science ®Google Scholar
• Daikoku T, Hirota Y, Tranguch S, Joshi AR, DeMayo FJ, Lydon JP, Ellenson LH, Dey SK. 2008. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res 68:5619–5627. http://dx.doi.org/10.1158/0008-5472.CAN-08-1274.
   PubMed Web of Science ®Google Scholar
• Strillacci A, Griffoni C, Sansone P, Paterini P, Piazzi G, Lazzarini G, Spisni E, Pantaleo MA, Biasco G, Tomasi V. 2009. MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res 315:1439–1447. http://dx.doi.org/10.1016/j.yexcr.2008.12.010.
   PubMed Web of Science ®Google Scholar
• Young LE, Moore AE, Sokol L, Meisner-Kober N, Dixon DA. 2012. The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2. Mol Cancer Res 10:167–180. http://dx.doi.org/10.1158/1541-7786.MCR-11-0337.
   PubMed Web of Science ®Google Scholar
• Agra Andrieu N, Motino O, Mayoral R, Llorente Izquierdo C, Fernandez-Alvarez A, Bosca L, Casado M, Martin-Sanz P. 2012. Cyclooxygenase-2 is a target of microRNA-16 in human hepatoma cells. PLoS One 7:e50935. http://dx.doi.org/10.1371/journal.pone.0050935.
   PubMedGoogle Scholar
• Valverde AM, Burks DJ, Fabregat I, Fisher TL, Carretero J, White MF, Benito M. 2003. Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes. Diabetes 52:2239–2248. http://dx.doi.org/10.2337/diabetes.52.9.2239.
   PubMed Web of Science ®Google Scholar
• Pepini T, Gorbunova EE, Gavrilovskaya IN, Mackow JE, Mackow ER. 2010. Andes virus regulation of cellular microRNAs contributes to hantavirus-induced endothelial cell permeability. J Virol 84:11929–11936. http://dx.doi.org/10.1128/JVI.01658-10.
   PubMed Web of Science ®Google Scholar
• Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. 2009. Modulation of microRNA processing by p53. Nature 460:529–533. http://dx.doi.org/10.1038/nature08199.
   PubMed Web of Science ®Google Scholar
• Huang WC, Chen CC. 2005. Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. Mol Cell Biol 25:6592–6602. http://dx.doi.org/10.1128/MCB.25.15.6592-6602.2005.
   PubMed Web of Science ®Google Scholar
• Mooney SM, Goel A, D'Assoro AB, Salisbury JL, Janknecht R. 2010. Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase. J Biol Chem 285:30443–30452. http://dx.doi.org/10.1074/jbc.M110.143792.
   PubMedGoogle Scholar
• Liang J, Liu C, Qiao A, Cui Y, Zhang H, Cui A, Zhang S, Yang Y, Xiao X, Chen Y, Fang F, Chang Y. 2013. MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesis. J Hepatol 58:535–542. http://dx.doi.org/10.1016/j.jhep.2012.10.024.
   PubMed Web of Science ®Google Scholar
• Iynedjian PB. 2009. Molecular physiology of mammalian glucokinase. Cell Mol Life Sci 66:27–42. http://dx.doi.org/10.1007/s00018-008-8322-9.
   PubMed Web of Science ®Google Scholar
• Xu J, Wong C. 2008. A computational screen for mouse signaling pathways targeted by microRNA clusters. RNA 14:1276–1283. http://dx.doi.org/10.1261/rna.997708.
   PubMed Web of Science ®Google Scholar
• Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R. 2004. The Microprocessor complex mediates the genesis of microRNAs. Nature 432:235–240. http://dx.doi.org/10.1038/nature03120.
   PubMed Web of Science ®Google Scholar
• Sakamoto S, Aoki K, Higuchi T, Todaka H, Morisawa K, Tamaki N, Hatano E, Fukushima A, Taniguchi T, Agata Y. 2009. The NF90-NF45 complex functions as a negative regulator in the microRNA processing pathway. Mol Cell Biol 29:3754–3769. http://dx.doi.org/10.1128/MCB.01836-08.
   PubMed Web of Science ®Google Scholar
• Dardenne E, Polay Espinoza M, Fattet L, Germann S, Lambert MP, Neil H, Zonta E, Mortada H, Gratadou L, Deygas M, Chakrama FZ, Samaan S, Desmet FO, Tranchevent LC, Dutertre M, Rimokh R, Bourgeois CF, Auboeuf D. 2014. RNA helicases DDX5 and DDX17 dynamically orchestrate transcription, miRNA, and splicing programs in cell differentiation. Cell Rep 7:1900–1913. http://dx.doi.org/10.1016/j.celrep.2014.05.010.
   PubMedGoogle Scholar
• Trabucchi M, Briata P, Filipowicz W, Rosenfeld MG, Ramos A, Gherzi R. 2009. How to control miRNA maturation? RNA Biol 6:536–540. http://dx.doi.org/10.4161/rna.6.5.10080.
   PubMed Web of Science ®Google Scholar
• Chen J, Halappanavar SS, St-Germain JR, Tsang BK, Li Q. 2004. Role of Akt/protein kinase B in the activity of transcriptional coactivator p300. Cell Mol Life Sci 61:1675–1683. http://dx.doi.org/10.1007/s00018-004-4103-9.
   PubMed Web of Science ®Google Scholar
• Kawai S, Amano A. 2012. BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex. J Cell Biol 197:201–208. http://dx.doi.org/10.1083/jcb.201110008.
   PubMed Web of Science ®Google Scholar
• Rybak A, Fuchs H, Smirnova L, Brandt C, Pohl EE, Nitsch R, Wulczyn FG. 2008. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat Cell Biol 10:987–993. http://dx.doi.org/10.1038/ncb1759.
   PubMed Web of Science ®Google Scholar
• Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT. 2008. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40:43–50. http://dx.doi.org/10.1038/ng.2007.30.
   PubMed Web of Science ®Google Scholar
• Dey I, Lejeune M, Chadee K. 2006. Prostaglandin E2 receptor distribution and function in the gastrointestinal tract. Br J Pharmacol 149:611–623. http://dx.doi.org/10.1038/sj.bjp.0706923.
   PubMed Web of Science ®Google Scholar
• Obermajer N, Kalinski P. 2012. Key role of the positive feedback between PGE(2) and COX2 in the biology of myeloid-derived suppressor cells. Oncoimmunology 1:762–764. http://dx.doi.org/10.4161/onci.19681.
   PubMed Web of Science ®Google Scholar
• Ceccarelli S, Panera N, Gnani D, Nobili V. 2013. Dual role of microRNAs in NAFLD. Int J Mol Sci 14:8437–8455. http://dx.doi.org/10.3390/ijms14048437.
   PubMed Web of Science ®Google Scholar
• Dávalos A, Goedeke L, Smibert P, Ramírez CM, Warrier NP, Andreo U, Cirera-Salinas D, Rayner K, Suresh U, Pastor-Pareja JC, Esplugues E, Fisher EA, Penalva LO, Moore KJ, Suárez Y, Lai EC, Fernández-Hernando C. 2011. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A 108:9232–9237. http://dx.doi.org/10.1073/pnas.1102281108.
   PubMed Web of Science ®Google Scholar
• Miller AM, Gilchrist DS, Nijjar J, Araldi E, Ramirez CM, Lavery CA, Fernandez-Hernando C, McInnes IB, Kurowska-Stolarska M. 2013. MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice. PLoS One 8:e72324. http://dx.doi.org/10.1371/journal.pone.0072324.
   PubMed Web of Science ®Google Scholar
• Hsieh PS, Jin JS, Chiang CF, Chan PC, Chen CH, Shih KC. 2009. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity (Silver Spring) 17:1150–1157. http://dx.doi.org/10.1038/oby.2008.674.
   PubMed Web of Science ®Google Scholar
• Hsieh PS, Lu KC, Chiang CF, Chen CH. 2010. Suppressive effect of COX2 inhibitor on the progression of adipose inflammation in high-fat-induced obese rats. Eur J Clin Invest 40:164–171. http://dx.doi.org/10.1111/j.1365-2362.2009.02239.x.
   PubMed Web of Science ®Google Scholar
• Tian YF, Hsia TL, Hsieh CH, Huang DW, Chen CH, Hsieh PS. 2011. The importance of cyclooxygenase 2-mediated oxidative stress in obesity-induced muscular insulin resistance in high-fat-fed rats. Life Sci 89:107–114. http://dx.doi.org/10.1016/j.lfs.2011.05.006.
   PubMedGoogle Scholar
• Coll T, Palomer X, Blanco-Vaca F, Escola-Gil JC, Sanchez RM, Laguna JC, Vazquez-Carrera M. 2010. Cyclooxygenase 2 inhibition exacerbates palmitate-induced inflammation and insulin resistance in skeletal muscle cells. Endocrinology 151:537–548. http://dx.doi.org/10.1210/en.2009-0874.
   PubMed Web of Science ®Google Scholar
• Taniguchi CM, Ueki K, Kahn R. 2005. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Invest 115:718–727. http://dx.doi.org/10.1172/JCI23187.
   PubMed Web of Science ®Google Scholar
• Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL. 2000. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6:77–86. http://dx.doi.org/10.1016/S1097-2765(05)00010-9.
   PubMed Web of Science ®Google Scholar
• van Rooij E, Purcell AL, Levin AA. 2012. Developing microRNA therapeutics. Circ Res 110:496–507. http://dx.doi.org/10.1161/CIRCRESAHA.111.247916.
   PubMed Web of Science ®Google Scholar
• Gebert LF, Rebhan MA, Crivelli SE, Denzler R, Stoffel M, Hall J. 2014. Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res 42:609–621. http://dx.doi.org/10.1093/nar/gkt852.
   PubMed Web of Science ®Google Scholar